NOD1 activation reportedly fosters an immunosuppressive tumour microenvironment to promote CRC development in both colitis‐associated carcinogenesis and spontaneous carcinogenesis (Maisonneuve et al., 2021). The gene discussed is NOD1; the disease is neoplasm.